VNDA ▲ +10.3% - Vanda Pharmaceuticals Inc.
$VNDA Vanda Pharma Q3 EPS $(0.37) Beats $(0.68) Estimate, Sales $69.815M Beat $69.202M Estimate / Vanda Pharmaceuticals FY2026 Revenue expected to be more than $240.000M vs $248.797M Est
28-OCT-2026 04:14 PM ET
Share this post
More filings for $VNDA
VNDA ▲ +10.5% - Vanda Pharmaceuticals Inc.Oct 28, 2026VNDA - Vanda Pharmaceuticals Inc. - SEC Filing Update (27-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 27, 2026VNDA ▼ -0.3% - Vanda Pharmaceuticals Inc.Oct 27, 2026VNDA ▼ -2.4% - Vanda Pharmaceuticals Inc.Oct 21, 2026VNDA ▼ -10.9% - Vanda Pharmaceuticals Inc.Oct 14, 2026VNDA ▼ -10.9% - Vanda Pharmaceuticals Inc.Oct 14, 2026
View full $VNDA filing history →💬 Comments
Loading comments…
Leave a comment